Search

Displaying results 4331 - 4340 of 10000 in total
  1. Drug

    Demelverine

    go.drugbank.com/drugs/DB20956
    Experimental

    Demelverine is a small molecule drug. The usage of the INN stem '-verine' in the name indicates that Demelverine is a spasmolytic with a papaverine-like action. … Demelverine has a monoisotopic molecular weight of 239.17 Da.

    Synonyms: N-methyldiphenethylamine
  2. Drug

    Cetocycline

    go.drugbank.com/drugs/DB20957
    Experimental

    Cetocycline is a small molecule drug. Cetocycline has a monoisotopic molecular weight of 411.13 Da.

  3. Drug

    Parbendazole

    go.drugbank.com/drugs/DB20965
    Experimental

    Parbendazole is a small molecule drug. Parbendazole has a monoisotopic molecular weight of 247.13 Da.

    Categories: Heterocyclic Compounds, 2-Ring
  4. Drug

    Pempidine

    go.drugbank.com/drugs/DB20967
    Experimental

    Pempidine is a small molecule drug. Pempidine has a monoisotopic molecular weight of 155.17 Da.

    Categories: Heterocyclic Compounds, 1-Ring
  5. Drug

    Cycliramine

    go.drugbank.com/drugs/DB20968
    Experimental

    Cycliramine is a small molecule drug. Cycliramine has a monoisotopic molecular weight of 298.12 Da.

  6. Drug

    Falipamil

    go.drugbank.com/drugs/DB20969
    Experimental

    Falipamil is a small molecule drug. Falipamil has a monoisotopic molecular weight of 428.23 Da.

    Categories: Heterocyclic Compounds, 2-Ring
  7. Drug

    Doqualast

    go.drugbank.com/drugs/DB20974
    Experimental

    Doqualast is a small molecule drug. Doqualast has a monoisotopic molecular weight of 240.05 Da.

    Categories: Heterocyclic Compounds, 2-Ring
  8. Drug

    Acetryptine

    go.drugbank.com/drugs/DB20978
    Experimental

    Acetryptine is a small molecule drug. Acetryptine has a monoisotopic molecular weight of 202.11 Da.

  9. Drug

    Lenacapavir

    go.drugbank.com/drugs/DB15673
    ApprovedInvestigational

    [A244170, A244175] Lenacapavir is a first-in-class capsid inhibitor that demonstrates picomolar HIV-1 inhibition as a monotherapy _in vitro_, little to no cross-resistance with existing antiretroviral

    Categories: P-glycoprotein inhibitors, P-glycoprotein substratesSynonyms: 1H-CYCLOPROPA(3,4)CYCLOPENTA(1,2-C)PYRAZOLE, N-((1S)-1-(3-(4-CHLORO-3-((METHYLSULFONYL)AMINO)-1-(2,2,2-TRIFLUOROETHYL)-1H-INDAZOL-7-YL)-6-(3-METHYL-3-(METHYLSULFONYL)-1-BUTYN-1-YL)-2-PYRIDINYL)-2-(3,5-, N-((1S)-1-(3-(4-CHLORO-3-(METHANESULFONAMIDO)-1-(2,2,2-TRIFLUOROETHYL)-1H-INDAZOL-7-YL)-6-(3-(METHANESULFONYL)-3-METHYLBUT-1-YN-1-YL)PYRIDIN-2-YL)-2-(3,5- DIFLUOROPHENYL)ETHYL)-2-((3BS,4AR)-5,5-DIFLUORO
  10. Drug

    Imlunestrant

    go.drugbank.com/drugs/DB19043
    ApprovedInvestigational

    Imlunestrant is a brain-penetrant selective estrogen receptor antagonist and degrader. … The FDA approved imlunestrant on September 25, 2025 [L54051] as a treatment for estrogen receptor (ER)-positive, HER2-negative, estrogen receptor 1 (ESR1)-mutated advanced or metastatic breast cancer with

    Categories: P-glycoprotein inhibitors, Cytochrome P-450 SubstratesSynonyms: (5r)-5-(4-(2-(3-(fluoromethyl)azetidin-1-yl)ethoxy)phenyl)-8-(trifluoromethyl)-5h-(1)benzopyrano(4,3-c)quinolin-2-ol, 5h-(1)benzopyrano(4,3-c)quinolin-2-ol, 5-(4-(2-(3-(fluoromethyl)-1-azetidinyl)ethoxy)phenyl)-8-(trifluoromethyl)-, (5r)-